1. Home
  2. RCMT vs KROS Comparison

RCMT vs KROS Comparison

Compare RCMT & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$25.55

Market Cap

196.0M

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$10.22

Market Cap

222.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCMT
KROS
Founded
1971
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.0M
222.3M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
RCMT
KROS
Price
$25.55
$10.22
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$36.00
$21.86
AVG Volume (30 Days)
76.4K
277.4K
Earning Date
04-03-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
27.38
146.00
EPS
0.52
N/A
Revenue
$186,737,000.00
$243,864,000.00
Revenue This Year
$11.89
N/A
Revenue Next Year
$12.46
$2,751.79
P/E Ratio
$48.21
N/A
Revenue Growth
5.83
N/A
52 Week Low
$17.26
$9.69
52 Week High
$32.50
$22.55

Technical Indicators

Market Signals
Indicator
RCMT
KROS
Relative Strength Index (RSI) 57.87 40.90
Support Level $17.77 $9.79
Resistance Level $27.62 $12.43
Average True Range (ATR) 0.98 0.46
MACD 0.48 -0.06
Stochastic Oscillator 100.00 26.80

Price Performance

Historical Comparison
RCMT
KROS

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: